We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 September 2024: OXB (LSE:OXB), a quality and innovation-led cell and...
Oxford Biomedica PLC 18 September 2024 Press release Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK - 18...
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica”, "OXB" or “the Company”), a quality and...
Oxford Biomedica PLC 02 September 2024 Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK - 2 September 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford...
Oxford Biomedica PLC 02 September 2024 Oxford Biomedica Total Voting Rights Oxford, UK - 02 September 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a...
Oxford Biomedica to host a free webinar showcasing its AAV expertise Oxford, UK - 27 August 2024: On Wednesday 11 September 2024, Oxford Biomedica, a quality and innovation-led cell and gene...
Oxford Biomedica PLC 09 August 2024 Oxford Biomedica Directorship notification under UK Listing Rule 6.4.9 (2) Oxford, UK - 9 August 2024: Oxford Biomedica plc (LSE:OXB) ("Oxford...
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on...
Half Year Trading Update and Notice of Interim Results Full year 2024 revenue and medium-term financial guidance reiterated; underpinned by OXB’s growing market share in the expanding cell and...
Oxford Biomedica PLC 08 August 2024 Half Year Trading Update and Notice of Interim Results - Full year 2024 revenue and medium-term financial guidance reiterated; underpinned by OXB's...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 20 | 6.05143721634 | 330.5 | 356.5 | 330.5 | 91545 | 347.13005735 | DE |
4 | 2.5 | 0.718390804598 | 348 | 358.5 | 320 | 109636 | 338.00490908 | DE |
12 | 37.5 | 11.9808306709 | 313 | 394 | 296 | 133535 | 344.36758768 | DE |
26 | 159.5 | 83.5078534031 | 191 | 394 | 185 | 202910 | 291.48770181 | DE |
52 | 108.5 | 44.8347107438 | 242 | 394 | 164.4 | 263790 | 238.13419784 | DE |
156 | -1071.5 | -75.3516174402 | 1422 | 1678 | 164.4 | 186394 | 453.95041292 | DE |
260 | -174.5 | -33.2380952381 | 525 | 1678 | 164.4 | 173714 | 610.51195514 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions